Canandaigua National Corp’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.32M Buy
+7,956
New +$8.07M 0.66% 30
2022
Q4
$2.38M Sell
6,492
-256
-4% -$90.8K 0.4% 74
2022
Q3
$2.18M Sell
6,748
-563
-8% -$178K 0.39% 78
2022
Q2
$2.37M Sell
7,311
-329
-4% -$98.8K 0.42% 71
2022
Q1
$2.19M Sell
7,640
-502
-6% -$129K 0.33% 86
2021
Q4
$2.25M Buy
8,142
+210
+3% +$53.2K 0.33% 85
2021
Q3
$1.83M Buy
7,932
+131
+2% +$32.3K 0.3% 99
2021
Q2
$1.79M Sell
7,801
-48
-0.6% -$9.64K 0.29% 97
2021
Q1
$1.47M Sell
7,849
-2,242
-22% -$439K 0.25% 112
2020
Q4
$1.7M Sell
10,091
-256
-2% -$38.2K 0.3% 93
2020
Q3
$1.53M Sell
10,347
-837
-7% -$130K 0.27% 99
2020
Q2
$1.84M Buy
+11,184
New +$1.72M 0.34% 81

Other funds holding LLY

Canandaigua National Corp's LLY Position: Q1 2026 in Review

Canandaigua National Corp opened a new position in Eli Lilly (LLY) in Q1 2026: 7,956 shares worth $7.32M. The stake represents 0.66% of the portfolio and ranks #30 among its holdings. This is a return to the name: Canandaigua National Corp previously reported a position in LLY as recently as Q4 2022.

Canandaigua National Corp first reported a position in LLY in Q2 2020 and has held it in 12 quarters since. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Canandaigua National Corp held 7,956 shares of Eli Lilly worth $7.32M as of Q1 2026.
  • Eli Lilly was a new Canandaigua National Corp position in Q1 2026.
  • Eli Lilly made up 0.66% of Canandaigua National Corp's portfolio in Q1 2026, its #30 holding.
  • Canandaigua National Corp first reported a position in Eli Lilly in Q2 2020 and has held it in 12 quarters since.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Canandaigua National Corp's 13F filing for Q1 2026, filed 8 Apr 2026.